The Genetic Control of HLA-A and B Antigens in Somatic Cell Hybrids: Requirement for β2Microglobulin-Reference-Cited by-同舟云学术

The Genetic Control of HLA-A and B Antigens in Somatic Cell Hybrids: Requirement for β2Microglobulin

Published:1978-02 Issue:2 Volume:11 Page:96-112
ISSN:0001-2815
Container-title:Tissue Antigens
language:en
Short-container-title:

Author:

Arce-Gomez Bento,Jones Elizabeth A.,Barnstable Colin J.,Solomon Ellen,Bodmer Walter F.

Publisher

Wiley

Subject

Genetics,Biochemistry,Immunology,General Medicine,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-0039.1978.tb01233.x/fullpdf

Reference48 articles.

1. Human chromosomes in 18 man-mouse cell hybrid cell lines analysed by quinacrine fluorescence;Allderdice;J. Cell Sci.,1973

2. Genetics and serology of human HLA linked Ia antigens;Barnstable;Cold Spring Harbor Symp. Quant. Biol.,1977

3. Synthesis, assembly and secretion of γ-globulin by mouse myeloma cells V. Balanced and unbalanced synthesis of heavy and light chain by IgG producing tumours and cell lines;Baumal;J. Immunol,1973

4. Isolation and properties of a low molecular weight β2 globulin occurring in human biological fluids;Beggard;J, Biol. Chem.,1968

5. Human intraspecific specific somatic cell hybrids: A genetic and karyotypic anslysis of crosses between lymphocytes and D98/AH-2;Bengtsson;Somatic Cell Genetics,1975

Cited by 206 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation;Frontiers in Immunology;2024-01-12

2. Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity;Stem Cell Research & Therapy;2023-01-24

3. Engineering Cell Lines for Specific Human Leukocyte Antigen Presentation;Methods in Molecular Biology;2023

4. CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma;Blood Advances;2022-04-25

5. Genome Editing of Pluripotent Stem Cells for Adoptive and Regenerative Cell Therapies;GEN Biotechnology;2022-02-01